focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 322.50
Bid: 321.00
Ask: 324.50
Change: -5.00 (-1.53%)
Spread: 3.50 (1.09%)
Open: 332.00
High: 332.00
Low: 321.00
Prev. Close: 327.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

28 Oct 2014 07:00

RNS Number : 4095V
Synthomer PLC
28 October 2014
 



28th October 2014

 

Synthomer plc

 

Interim Management Statement

 

Synthomer plc ("Synthomer" or "the Group") today issues its Interim Management Statement for the period 1 July to 28 October 2014.

 

Trading

 

At our interim results on August 11th 2014, we reported firmer demand in our European and North America (ENA) segment, particularly in construction. Unfortunately this improved demand trend has not persisted through the third quarter and volumes, excluding business that we deliberately exited in compounds as reported in half one, were down 3% in ENA. Despite this, unit cash margins continued to firm as a result of our active margin management strategy, and year-to-date average margins in ENA are now ahead of the 2013 average. However, on a local currency basis, as at the end of the third quarter, year-to-date operating profit was slightly down on the prior year.

 

In our Asia and Rest of the World (ARW) segment, volumes increased by 1.3% in the quarter. Volumes have been impacted somewhat by our market activities to improve unit cash margins in the nitrile business, where we have made good progress. We remain positive about continuing demand growth in the nitrile latex market.

 

Financial Position

 

The balance sheet remains in a strong position with the net debt / EBITDA ratio at approximately 1x.

 

We completed the purchase of the other 50% of our EKA Synthomer JV in Finland in October from Akzo Nobel for €5 million. The entity has some €6 million of debt at the transaction date which will be consolidated at the year end, meaning year end net debt for the Group will be slightly higher than previous expectations, and is likely to be similar to the mid-year position.

 

Consistent with our capital management policy articulated at the interim results, if excess capital has not been deployed for either bolt-on acquisitions or capital expenditure, at the year end the Board will consider a one-off capital return to shareholders to maintain an efficient balance sheet.

 

Outlook

At current run rates and given the current demand environment in Europe, the Board now expects full year profit-before-tax to be slightly below current consensus1. We are cautious about performance in Europe given recent economic developments, and should this impact demand further than currently anticipated in the fourth quarter, then profit-before-tax is likely to be around the lower end of the current consensus range2.

 

1. Company compiled 2014 consensus PBT: £87.8 million

2. Company compiled 2014 consensus PBT range: £81.3million - £90.3 million

 

  

Enquiries:

 

Adrian Whitfield, Chief Executive Officer

Charles Armitstead / Rebecca Hall

David Blackwood, Chief Financial Officer

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

 

 

The company will host a conference call for analysts at 8.30am today. Please contact Pendomer Communications on 020 3603 5220 for dial in details.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUBVNRSRARUAA
Date   Source Headline
1st Jul 20167:00 amRNSCompletion of acquisition and trading update
31st May 201611:31 amRNSAudit Tender
16th May 20164:17 pmRNSHolding(s) in Company
9th May 201612:31 pmRNSDirector/PDMR Shareholding
28th Apr 20163:11 pmRNSResult of AGM
28th Apr 20167:00 amRNSQ1 Trading update
21st Apr 20161:44 pmRNSHolding(s) in Company
20th Apr 20162:23 pmRNSDirector Declaration
11th Apr 20163:01 pmRNSDirector/PDMR Shareholding
11th Apr 20163:00 pmRNSDirector/PDMR Shareholding
31st Mar 20162:15 pmRNSAnnual Financial Report
21st Mar 20167:00 amRNSAcquisition
21st Mar 20167:00 amRNSDisposal
15th Mar 201612:29 pmRNSHolding(s) in Company
2nd Mar 20167:00 amRNSPreliminary Results for the year ended 31 Dec 2015
10th Feb 20167:00 amRNSFRS 101 Notification
5th Feb 20163:34 pmRNSHolding(s) in Company
5th Feb 20163:13 pmRNSHolding(s) in Company
30th Nov 20153:00 pmRNSHolding(s) in Company
18th Nov 201510:30 amRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSQ3 Trading Update
1st Oct 201512:50 pmRNSHolding(s) in Company
13th Aug 201510:05 amRNSHolding(s) in Company
11th Aug 20157:00 amRNSHalf Yearly Results
10th Jul 20152:43 pmRNSDirector/PDMR Shareholding
9th Jul 20159:12 amRNSHolding(s) in Company
7th Jul 20154:21 pmRNSHolding(s) in Company
6th Jul 20153:59 pmRNSHolding(s) in Company
2nd Jul 20157:00 amRNSTrading Update
22nd Jun 20153:51 pmRNSHolding(s) in Company
20th May 20158:57 amRNSHolding(s) in Company
14th May 201510:02 amRNSDirector/PDMR Shareholding
30th Apr 201512:53 pmRNSResult of AGM
30th Apr 201512:46 pmRNSDirectorate Change
30th Apr 20157:00 amRNSQuarter 1 Trading Update
27th Apr 201510:36 amRNSDirectorate Change
21st Apr 20155:16 pmRNSHolding(s) in Company
1st Apr 20158:15 amRNSDirectorate Change
31st Mar 20159:25 amRNSAnnual Financial Report
30th Mar 201510:13 amRNSHolding(s) in Company
27th Mar 201512:53 pmRNSDirector/PDMR Shareholding
23rd Mar 20157:00 amRNSDirectorate Change
19th Mar 201511:53 amRNSDirector Declaration
18th Mar 20154:47 pmRNSDirector/PDMR Shareholding
13th Mar 20159:35 amRNSHolding(s) in Company
27th Feb 20153:06 pmRNSDirector/PDMR Shareholding
27th Feb 20153:05 pmRNSDirector/PDMR Shareholding
26th Feb 20157:01 amRNSFinal Results
20th Jan 20151:58 pmRNSNotice of Results
16th Jan 20157:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.